173 related articles for article (PubMed ID: 21837739)
1. Model for end-stage liver disease exceptions: proceed with caution.
Washburn K
Liver Transpl; 2011 Oct; 17(10):1123-4. PubMed ID: 21837739
[No Abstract] [Full Text] [Related]
2. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
[TBL] [Abstract][Full Text] [Related]
3. Liver allocation for patients with hepatocellular carcinoma.
Neuberger J
Liver Transpl; 2010 Mar; 16(3):249-51. PubMed ID: 20209584
[No Abstract] [Full Text] [Related]
4. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
Shneider BL; Suchy FJ; Emre S
Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
[TBL] [Abstract][Full Text] [Related]
5. [The value of MELD in the allocation of priority for liver transplantation candidates].
Colmenero J; Castro-Narro G; Navasa M
Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
[TBL] [Abstract][Full Text] [Related]
6. Candidate selection and organ allocation in liver transplantation.
Dawwas MF; Gimson AE
Semin Liver Dis; 2009 Feb; 29(1):40-52. PubMed ID: 19235658
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation: Toward a unified allocation system.
Zarrinpar A; Busuttil RW
Nat Rev Gastroenterol Hepatol; 2011 Oct; 8(10):542-3. PubMed ID: 21970965
[No Abstract] [Full Text] [Related]
8. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.
Pomfret EA; Washburn K; Wald C; Nalesnik MA; Douglas D; Russo M; Roberts J; Reich DJ; Schwartz ME; Mieles L; Lee FT; Florman S; Yao F; Harper A; Edwards E; Freeman R; Lake J
Liver Transpl; 2010 Mar; 16(3):262-78. PubMed ID: 20209641
[TBL] [Abstract][Full Text] [Related]
9. [Liver transplantation - current aspects of allocation, indication and donor pool expansion].
Settmacher U; Scheuerlein H; Dittmar Y; Rauchfuss F
Zentralbl Chir; 2013 Dec; 138(6):604-10. PubMed ID: 23238834
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk, behavior, and pediatric liver allocation.
Freeman RB
Liver Transpl; 2006 Jan; 12(1):12-5. PubMed ID: 16382452
[No Abstract] [Full Text] [Related]
11. Selection of candidates with HCC for transplantation in the MELD era.
Sala M; Varela M; Bruix J
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
[TBL] [Abstract][Full Text] [Related]
12. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
[TBL] [Abstract][Full Text] [Related]
13. Who should get a liver graft?
Freeman RB; Jamieson N; Schaubel DE; Porte RJ; Villamil FG
J Hepatol; 2009 Apr; 50(4):664-73. PubMed ID: 19233503
[No Abstract] [Full Text] [Related]
14. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
Monteiro F; Coria SA; Boni R; Pereira LA
Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
[TBL] [Abstract][Full Text] [Related]
15. Liver transplant recipient selection: MELD vs. clinical judgment.
Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
[TBL] [Abstract][Full Text] [Related]
16. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.
Wald C; Russo MW; Heimbach JK; Hussain HK; Pomfret EA; Bruix J
Radiology; 2013 Feb; 266(2):376-82. PubMed ID: 23362092
[No Abstract] [Full Text] [Related]
17. A UNOS perspective on donor liver allocation. United Network for Organ Sharing.
Bollinger RR
Liver Transpl Surg; 1995 Jan; 1(1):47-55; discussion 80-2. PubMed ID: 9346541
[No Abstract] [Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
Roayaie S; Llovet JM
Clin Liver Dis; 2005 May; 9(2):315-28. PubMed ID: 15831276
[TBL] [Abstract][Full Text] [Related]
19. Is tumor biopsy necessary?
Müllhaupt B; Durand F; Roskams T; Dutkowski P; Heim M
Liver Transpl; 2011 Oct; 17 Suppl 2():S14-25. PubMed ID: 21744470
[No Abstract] [Full Text] [Related]
20. Should we change the priority for liver allocation for patients with the highest MELD score?
Freeman RB; Wiesner R
Hepatology; 2012 Jan; 55(1):14-5. PubMed ID: 22095707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
